Degarelix

Overview

Degarelix acetate is a reversible gonadotropin-releasing hormone receptor (GnRHR) antagonist. Degarelix reduces the secretion of luteinizing hormone (LH) and testosterone via blocking GnRHR. Degarelix can be used for the treatment of prostate cancer. Sequence: Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Phe(4-S-dihydroorotamido)-D-Phe(4-ureido)-Leu-Lys(iPr)-Pro-D-Ala-NH2 Source summary: Degarelix is a potent GnRH antagonist peptide applied in prostate cancer and hormonal suppression studies. Discover this therapeutic peptide today!

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | GNRH Receptor

Product Information

• Catalog No.: B0084-465293
• CAS No.: 214766-78-6
• Molecular Formula: C82H103ClN18O16
• Molecular Weight: 1632.286
• Purity: >98%
• Storage: Store at -20°C

Source

Original product source